免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

LEXURE for Post-Stroke Aphasia

NCT:NCT07570264 · RECRUITING

NCT编号NCT07570264
状态RECRUITING
开始日期2026-04-16
完成时间2026-12-30
SponsorNunaps Inc (INDUSTRY)
First posted
Last updated

简要摘要

This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑